BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin

Ralph J. Abi‐Habib(Wake Forest University), Arthur E. Frankel(Scott & White Memorial Hospital)
Molecular Cancer Therapeutics
September 1, 2005
Cited by 73


Related Papers